US Oncology Reports Fourth Quarter and Fiscal Year 20...(71021 66674 Total current ...)

Total current assets 776,333 899,080

Property and equipment, net 399,621 393,318

Service agreements, net 223,850 240,100

Goodwill 757,270 757,870

Other assets 79,299 76,126

$2,236,373 $2,366,494

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Current maturities of long-term indebtedness $38,613 $9,397

Accounts payable 242,172 198,978

Dividends payable - 190,000

Due to affiliates 170,432 146,683

Accrued compensation cost 30,045 26,854

Accrued interest payable 24,949 30,965

Income taxes payable - 1,842

Other accrued liabilities 37,763 32,565

Total current liabilities 543,974 637,284

Deferred revenue 8,380 8,337

Deferred income taxes 23,289 33,520

Long-term indebtedness 1,456,569 1,319,664

Other long-term liabilities 39,492 8,032

Total liabilities 2,071,704 2,006,837

Minority interests 13,217 14,148

Preferred stock Series A, 15,000 shares authorized,

13,939 shares issued and outstanding, respectively 308,174 312,749

Preferred stock Series A-1, 2,000 shares authorized,

1,948 shares issu
'/>"/>